49
Participants
Start Date
September 22, 2009
Primary Completion Date
March 9, 2010
Study Completion Date
March 9, 2010
Zolpidem or placebo - Hypnotic drug given for sleep disorders
The information gathered from Part A will be used as a benchmark against which any effects of GSK1521498 can be assessed in Part B.
GSK1521498 or placebo
The first group will start at a low dose (10 mg GSK1521498 or placebo) for 10 days. The study team will then assess the data gathered from the first cohort and will select the dose that the next cohort will receive for 10 days. There will be up to 4 cohorts.
GSK Investigational Site, Cambridge
Lead Sponsor
GlaxoSmithKline
INDUSTRY